Role of selenium compounds on tyrosine hydroxylase activity, adrenomedullin and total RNA levels in hearts of rats

Regulatory Peptides

Volumn 159, Issue 1-3, 2010, Pages 137-141

  Talas, Zeliha Selamoglu ^a   Ozdemir, Ilknur ^b   Gok, Yetkin ^b   Ates, Burhan ^b   Yilmaz, Ismet ^b  

^a NIGDE UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Adrenomedullin; Heart; Organoselenium compounds; Rat; Tyrosine hydroxylase

Indexed keywords

1 ISOPROPYL 3 METHYL BENZIMIDAZOLE 2 SELENONE; 1,3 BIS(4 METHOXYBENZYL)PYRIMIDINE 2 SELENONE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ADRENOMEDULLIN; CATECHOLAMINE; DNA; NATRIURETIC FACTOR; ORGANOSELENIUM DERIVATIVE; RNA; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; FEMALE; HEART FAILURE; ISOLATED HEART; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; VASODILATATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADRENOMEDULLIN; ANIMALS; ANTIHYPERTENSIVE AGENTS; CARCINOGENS; FEMALE; MYOCARDIUM; ORGANOSELENIUM COMPOUNDS; OXIDATIVE STRESS; RATS; RATS, WISTAR; RNA; TYROSINE 3-MONOOXYGENASE;

RATTUS; RATTUS NORVEGICUS;

EID: 71349085372     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.08.009     Document Type: Article

References (42)

1. Al-Smadi M., and Al-Momani F. Synthesis, characterization and antimicrobial activity of new 1, 2, 3-selenadiazoles. Molecules 13 (2008) 2740-2749
2. Perottoni J, OED, Rodrigues MW, Paixão G, Zeni LP, Lobato AL, Braga JBT, Rocha T. Emanuelli, Renal and hepatic ALA-D activity and selected oxidative stress parameters of rats exposed to inorganic mercury and organoselenium compounds. Food Chem. Toxicol. 2004; 42: 17-28
3. Fener T., and Schiesser C.H. Toward pyridine-fused selenium-containing antioxidants. Molecules 9 (2004) 472-479
4. Alissa E.M., Ahmed W.H., Al-ama N., and Ferns G.A.A. Selenium status and cardiovascular risk profile in healthy adult Saudi Males. Molecules 14 (2009) 141-159
5. Behne D., and Kyriakopoulos A. Mammalian selenium-containing proteins. Ann Rev Nutr 21 (2001) 453-473
6. Garud D.R., Koketsu M., and Hideharu I. Isoselenocyanates: a powerful tool for the synthesis of selenium-containing heterocycles. Molecules 12 (2007) 504-535
7. Shi H., Hudson L.G., and Liu K.J. Oxidative stress and apoptosis in metal ion-induced carcinogenesis. Free Radic Bio Med 37 (2004) 582-593
8. Hintz F.H. The many phases of selenium. Nutrition. World Equine Veterinary Review 4 (1999) 9-22
9. Sieja K., and Talerczyk M. Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy. Gynecol Oncol 93 (2004) 320-327
10. Mugesh G., Mont W.W., and Sies H. Chemistry of biologically important synthetic organoselenium compounds. Chem Rev 101 (2001) 2125-2179
11. Das R.K., Ghosh S., Sengupta A., Das S., and Bhattacharya S. Inhibition of DMBA/croton oil-induced two-stage mouse skin carcinogenesis by diphenylmethyl selenocyanate. Eur J Cancer Prev 13 (2004) 411-417
12. Arteel G.E., and Sies H. The biochemistry of selenium and the glutathione system. Environ Toxicol Pharmacol 10 (2001) 153-158
13. Talas Z.S., Ozdemir I., Yi{dotless}lmaz I., Gok Y., and Orun I. The investigation of the antioxidative properties of the novel synthetic organoselenium compounds in the some rat tissues. Exp Biol Med 233 (2008) 575-579
14. Demir I., and Demirbag Z. Biodegradation of polycyclic aromatic hydrocarbons. Tr J Biol 23 (1999) 293-302
15. Desai G.V., Casciano D., Feuers J.R., and Aidoo A. Activity profile of glutathione dependent enzymes and respiratory chain complexes in rats supplemented with antioxidants and treated with carcinogens. Arch Biochem Biophys 394 (2001) 255-264
16. Sun W. Reactive oxygen species and breast cancer carcinogenesis. Breast Cancer 2001; 77-222.
17. El-Demerdash F.M. Antioxidant effect of vitamin E and selenium on lipid peroxidation, enzyme activities and biochemical parameters in rats exposed to aluminium. J Trace Elem Med Biol 18 (2004) 113-121
18. Devillers I., Dive G., De Tollenaere C., Falmagne B., de Wergifosse B., Rees J.F., et al. Imidazolopyrazinones as potential antioxidants. Bioorg Med Chem 11 (2001) 2305-2309
19. Yoshihara F., Shin-ichi S., Yasui N., Takeshi H., Tokudome T., Nishikimi T., et al. Chronic administration of adrenomedullin attenuates the hypertension and increases renal nitric oxide synthase in Dahl salt-sensitive rats. Regul Peptides 128 1 (2005) 7-13
20. Tambara K., Fujita M., Nagaya N., Miyamoto S., Iwakura A., Doi K., et al. Increased pericardial fluid concentrations of the mature form of adrenomedullin in patients with cardiac remodelling. Heart 87 (2002) 242-246
21. Chao J., and Chao L. The role of adrenomedullin in cardiovascular and renal function. Drug News Perspect 15 8 (2002) 511
22. Yurekli M. The effects of phenoxybenzamine on tyrosine hydroxylase (TH) and TH mRNA level in adrenal medulla of Sprague Dawley rats. Tr J Med Sci 28 (1998) 35-39
23. Ozdemir I., Selamoglu Z., Ates B., Gok Y., and Yilmaz I. Modulation of DMBA-induced biochemical changes by organoselenium compounds in blood of rats. Indian J Biochem Biophys 44 4 (2007) 257-259
24. Talas Z.S., Yilmaz I., Ozdemir I., Ates B., Gok Y., and Cetinkaya B. Role of synthesized organoselenium compounds on protection of rat erythrocytes from DMBA-induced oxidative stress. Biol Trace Elem Res 128 2 (2009) 167-175
25. Washington DC. Guide for the care and use of laboratory animals. National Academy Press, 1996.
26. 4Se. Anal Sci 19 (2003) 1093-1094
27. Gok Y., Cetinkaya E., Ozdemir I., Cetinkaya B., and Lappert M.F. Synthesis and characterisation of N-functionalized enetetramines, and their properties. Acta Chim Slov 51 (2004) 437-446
28. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72 (1976) 248-254
29. Mant C.T., and Hudges R.S. Analysis of peptides by high performance liquid chromatography. Methods Enzymol 271 (1996) 3
30. 3[H]-tyrosine by charcoal. Life Sci 39 (1986) 2185-2189
31. Chomzynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Bio Chem 162 (1987) 156-159
32. Iemura-Inaba C., Nishikimi T., Akimoto K., Yoshihara F., Minamino N., and Matsuoka H. Role of adrenomedullin system in lipid metabolism and its signaling mechanism in cultured adipocytes. Am J Physiol Regul Integr Comp Physiol 295 5 (2008) 1376-1384
33. Miriam T., Rademaker C.J., Charles E.A., Espiner M., Gary N.A., and Richards M. Long-term adrenomedullin administration in experimental heart failure. Hypertension 40 (2002) 667-672
34. Johji K., Kazuo K., and Tanenao E. Roles of adrenomedullin in hypertension and hypertensive organ damage. Curr Hypertens Rev 2 4 (2006) 283-295
35. Pousset F., Masson F., Chavirovskaia O., Isnard R., Carayon A., Golmard J.L., Lechat P., Thomas D., and Komajda M. Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure. Eur Heart J 21 (2000) 1009-1014
36. Jougasaki M., and Burnett Jr. J.C. Adrenomedullin as a renal regulator peptide. Nephrol Dial Transplant 15 (2000) 293-295
37. Pool P.E., Covell J.W., Levitt M., Gibb J., and Braunwald E. Reduction of cardiac tyrosine hydroxylase activity in experimental congestive heart failure: i{dotless}ts role in the depletion of cardiac norepinephrine stores. Circ Res 20 (1967) 349-353
38. Talas Z.S., and Yurekli M. The effects of enalapril maleate and cold stress exposure on tyrosine hydroxylase activity in some rat tissues. Cell Biochem Funct 24 (2006) 537-540
39. Parrish D.C., Gritman K., Van Winkle D.M., Woodward W.R., Bader M., and Habecker B.A. Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter. Am. J. Physiol. Heart Circ. Physiol. 294 1 (2008) 99-106
40. Reynolds J.E.F. Martindale: the extra pharmacopoeia (31st ed) (1996), The Royal Pharmaceutical Society, London
41. Fregly M.J., Kikta D.C., Threatte R.M., Torres J.L., and Barney C.C. Development of hypertension in rats during chronic exposure to cold. J Appl Physiol 66 2 (1989) 741-749
42. Sun Z., Cade J.R., and Fregly M.J. Cold-induced hypertension. A model of mineralocorticoid-induced hypertension. Ann NY Acad Sci 813 (1997) 682-688